Conference
Prospective Multicentre trial of bridging therapy with dalteparin for patients who require temporary discontinuation of OAC for prosthetic valves or high risk atrial fibrillation.
Authors
Kovacs M; Kahn S; Solymoss S; Anderson D; Desjardins L; Rodger M; Turpie A; Bates S; Douketis J; Kearon C
Volume
100
Pagination
pp. 149A-149A
Publisher
AMER SOC HEMATOLOGY
Publication Date
November 16, 2002
Name of conference
44th Annual Meeting of the American-Society-of-Hematology
Conference place
PHILADELPHIA, PENNSYLVANIA
Conference start date
December 6, 2002
Conference end date
December 10, 2002
Conference proceedings
BLOOD
Issue
11
ISSN
0006-4971